MedTrace Logo

Biliverdin Reductase A in Chronic Hepatitis C Virus Infection

NCT01112033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2015-08-07

No results posted yet for this study

Summary

In this project, the investigators aim to study the role of biliverdin reductase A (BLVRA) in HCV infected patients prior and during/after standard antiviral therapy in association with viral clearance, disease progression and treatment response and in comparison with healthy subjects.

Conditions

  • Hepatitis C, Chronic

Sponsors & Collaborators

  • Military University Hospital, Prague

    collaborator OTHER

  • General University Hospital, Prague

    collaborator OTHER

  • Institute for Clinical and Experimental Medicine

    collaborator OTHER_GOV

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Iva Subhanova · Charles University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-03-31
Completion
2013-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112033 on ClinicalTrials.gov